ZA943808B - Use of O-esters of L-carnitine with aromatic acids for producing pharmaceutical compositions for the treatment of dermatoses - Google Patents

Use of O-esters of L-carnitine with aromatic acids for producing pharmaceutical compositions for the treatment of dermatoses

Info

Publication number
ZA943808B
ZA943808B ZA943808A ZA943808A ZA943808B ZA 943808 B ZA943808 B ZA 943808B ZA 943808 A ZA943808 A ZA 943808A ZA 943808 A ZA943808 A ZA 943808A ZA 943808 B ZA943808 B ZA 943808B
Authority
ZA
South Africa
Prior art keywords
carnitine
esters
pharmaceutical compositions
dermatoses
aromatic acids
Prior art date
Application number
ZA943808A
Other languages
English (en)
Inventor
Claudio Cavazza
Paolo Cavazza
Original Assignee
Avantgarde Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avantgarde Spa filed Critical Avantgarde Spa
Publication of ZA943808B publication Critical patent/ZA943808B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
ZA943808A 1993-06-02 1994-06-01 Use of O-esters of L-carnitine with aromatic acids for producing pharmaceutical compositions for the treatment of dermatoses ZA943808B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM930365A IT1261696B (it) 1993-06-02 1993-06-02 Uso di esteri sull'ossidrile della l-carnitina con acidi aromatici perprodurre composizioni farmaceutiche per il trattamento di affezioni cutanee.

Publications (1)

Publication Number Publication Date
ZA943808B true ZA943808B (en) 1995-01-30

Family

ID=11401791

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA943808A ZA943808B (en) 1993-06-02 1994-06-01 Use of O-esters of L-carnitine with aromatic acids for producing pharmaceutical compositions for the treatment of dermatoses

Country Status (12)

Country Link
US (1) US5639767A (xx)
EP (1) EP0628308B1 (xx)
JP (1) JPH07309820A (xx)
KR (1) KR950000141A (xx)
AT (1) ATE174216T1 (xx)
CA (1) CA2124748A1 (xx)
DE (1) DE69415081T2 (xx)
DK (1) DK0628308T3 (xx)
ES (1) ES2126674T3 (xx)
GR (1) GR3029536T3 (xx)
IT (1) IT1261696B (xx)
ZA (1) ZA943808B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833998A (en) * 1995-11-06 1998-11-10 The Procter & Gamble Company Topical compositions for regulating the oily/shiny appearance of skin
IT1276253B1 (it) 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US5863940A (en) 1997-12-01 1999-01-26 Sigma-Tau Healthscience S.P.A. Medicament and therapeutical method for treating idiopathic asthenozoospermia
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
PT951909E (pt) 1998-03-19 2004-04-30 Sigma Tau Ind Farmaceuti Composicao combinada que contem uma l-carnitina ou uma alcanoil-l-carnitina um glicosaminoglicano e/ou um seu constituinte
DE10129502A1 (de) * 2001-06-19 2003-01-09 Beiersdorf Ag Verwendung von Carnitin und/oder einem oder mehreren Acyl-Carnitinen zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Steigerung der Ceramidbiosynthese
DE10133200A1 (de) 2001-07-07 2003-01-23 Beiersdorf Ag Carnitin enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
ITRM20020055A1 (it) * 2002-02-04 2003-08-04 Aldo Fassi Sali metallici di carnitine, integratori dietetici/nutritivi che li contengono e kit dietetici per contrastare disturbi sessuali in soggetti
KR100783145B1 (ko) * 2002-04-23 2007-12-07 삼성광주전자 주식회사 선회형 흡입구를 가지는 청소 로봇
ES2336995B1 (es) 2008-10-13 2011-02-09 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas.
US9259343B2 (en) 2012-07-06 2016-02-16 Newman Technologies LLC Device for mitigating plantar fasciitis
CN107540605B (zh) * 2016-12-28 2020-03-06 宁波见睿新材料有限公司 用于头发或头皮护理的胆碱酯类化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2354769A1 (fr) * 1976-06-15 1978-01-13 Tanabe Seiyaku Co Derives de nicotinoylcarnitines, leur preparation et leurs utilisations therapeutiques
CH679856A5 (xx) * 1990-07-04 1992-04-30 Lonza Ag

Also Published As

Publication number Publication date
DK0628308T3 (da) 1999-08-16
CA2124748A1 (en) 1994-12-03
DE69415081D1 (de) 1999-01-21
DE69415081T2 (de) 1999-04-29
US5639767A (en) 1997-06-17
ES2126674T3 (es) 1999-04-01
ITRM930365A0 (it) 1993-06-02
EP0628308B1 (en) 1998-12-09
ATE174216T1 (de) 1998-12-15
KR950000141A (ko) 1995-01-03
ITRM930365A1 (it) 1994-12-02
IT1261696B (it) 1996-05-29
GR3029536T3 (en) 1999-06-30
EP0628308A1 (en) 1994-12-14
JPH07309820A (ja) 1995-11-28

Similar Documents

Publication Publication Date Title
ZA944413B (en) Use of o-esters of l-carnitine and acyl l-carnitine with hydroxyacids for producing pharmaceutical compositions for treating dermatoses
US5091171B1 (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
ZA943808B (en) Use of O-esters of L-carnitine with aromatic acids for producing pharmaceutical compositions for the treatment of dermatoses
ZA943727B (en) Use of o-esters of l-carnitine for producing pharmaceutical compositions for the reatment of dermatoses
SG47035A1 (en) Method of topically treating acne vulgaris
HK1005589A1 (en) Esters of l-carnitine and alkanoyl l-carnitines with glycolic acid or esters thereof and pharmaceutical compositions containing same for treating dermatoses
DK0700898T3 (da) L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme, til behandling af dermatoser.
AU1271592A (en) Malic acid derivatives and compositions for the treatment of psoriasis
PH31608A (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses.
NO962619D0 (no) Psoriasisbehandling
BR9206750A (pt) Processo para controlar concentração de produto de ácido fosfórico
PT84694B (pt) Processo para a preparacao de composicoes cardiovasculares topicas contendo um ester de acido nitrico
IT1262956B (it) Composizione e suo uso per il trattamento terapeutico di affezioni dermatitiche, particolarmente la psoriasi.